COVID-19 Resources for National HIV Programs
Tools and resources to support national HIV programs, implementing partners, and community advocates in COVID-19 preparedness
In an effort to share key COVID-19 HIV tools and resources with global stakeholders, CHAI will be updating this webpage on a regular basis and as new resources are shared. If there are any HIV-specific tools and resources that you would like to recommend for inclusion on the New Product Introduction Toolkit, please email HIVToolkit@clintonhealthaccess.org.
Key CHAI Tools and Resources
 |
|---|
 |
 |
 |
 |
PEPFAR, Global Fund, and WHO Guidance
-
Plans for Resumption of PEPFAR COP/ROP 2021 Planning Process *NEW
-
PEPFAR Technical Guidance in the Context of COVID-19 Pandemic *Recently updated
-
Global Fund COVID-19 Information note: Considerations for Global Fund support of HIV
-
Actions to Take to Ensure Supplies are Available (USAID-GHSCP)
-
Disruption in HIV, Hepatitis and STI services due to COVID-19 (WHO)
Community Resources
AfroCAB/CHAI
aidsmap
CDC Foundation/Project ECHO
CQUIN
FHI 360
-
Strategic Considerations for Mitigating the Impact of COVID-19 on Key-Population-Focused HIV Programs (April 2020)
HIV i-Base
IAS
UNAIDS
-
Rights in the time of COVID-19: Lessons from HIV for an effective, community-led response
-
What PLHIV need to know about HIV and COVID-19: Brochure | Infographics
-
Maintaining and prioritizing HIV prevention services in the time of COVID-19
-
Lessons from HIV prevention for preventing COVID-19 in low-and middle-income countries (April 2020)
-
Addressing stigma and discrimination in the COVID-19 response
UNICEF
 |
|---|
 |
 |
 |
Clinical Evidence Resources on COVID-19 and HIV
-
Therapeutic Options for COVID-19 Currently Under Investigation (NIH, Ongoing)
-
A Trial of LPV/r in Adults Hospitalized with Severe COVID-19 (NEJM, March 2020)
-
Systematic Review of the efficacy and safety of ARVs against SARS, MERS, of COVID-19 (JIAS, March 2020)
-
COVID-19 in Patients with HIV: Clinical Case Series (Lancet, April 2020)
-
Darunavir does not prevent SARS CoV-2 infection in HIV patients (Pharmacological Research, April 2020)
-
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients (Journal of Infectious Disease, May 2020)
-
Spanish study raises possibility that old-style tenofovir might protect against COVID-19 (aidsmap, June 2020)
-
COVID-19, HIV and TB Webinar - COVID-19 and TPT (Arum Institute, June 2020)
-
COVID-19, HIV and TB Webinar - Dr. Mary-Ann Davies, Western Cape Department of Health: Preliminary Analysis of Risk Factors for COVID-19 deaths in the province (Arum Institute, June 2020)
-
London study shows people with HIV not at greater risk of severe COVID-19 illness (aidsmap, July 2020)
-
COVID-19 affects HIV and tuberculosis care (AAAS Science, July 2020)
-
No link between HIV status and coronavirus outcomes in large US study (aidsmap, July 2020)
-
Two UK studies find that HIV infection may be a risk factor for dying from COVID-19 (aidsmap, August 2020)
-
High prevalence of underlying health conditions explains increased COVID-19 mortality seen in people with HIV in US study (aidsmap, September 2020)
-
COVID-19 more prevalent among general vs HIV-positive population, Barcelona study says (AJMC, September 2020)
-
Preventive efficacy of tenofovir/emtricitabine against SARS-CoV-2 among PrEP users (Oxford Academy, September 2020)
-
Characteristics, comorbidities and outcomes in a multicenter registry of patients with HIV and Coronavirus Disease-19 (Oxford Academy, September 2020)
-
US study of HIV-positive people with COVID-19 reports worse outcomes with comorbidities and having a CD4 <200 (i-base, October 2020)
-
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis (Lancet, February 2021) *NEW
-
'Resilient' HIV programmes in African countries have maintained viral suppression during the COVID-19 pandemic (aidsmap, March 2021) *NEW
Global Stakeholder COVID-19 Response Resources
